Vascular calcification relationship to vascular biomarkers and bone metabolism in advanced chronic kidney disease

Syazrah Salam1, Orla Gallagher2, Fatma Gossiel2

  • 1Sheffield Kidney Institute, Sheffield Teaching Hospitals NHS Foundation Trust, United Kingdom; Academic Unit of Bone Metabolism and Mellanby Centre for Bone Research, University of Sheffield, United Kingdom.

Bone
|October 22, 2020
PubMed

Insights

Vascular calcification (VC) is more severe in advanced chronic kidney disease (CKD) patients, particularly those with diabetes. Higher levels of parathyroid hormone (PTH) and fibroblast growth factor-23 (FGF23) are linked to increased VC in CKD.

Area of Science:

  • Nephrology
  • Endocrinology
  • Radiology

Background:

  • Vascular calcification (VC) and renal osteodystrophy are significant complications in advanced chronic kidney disease (CKD).
  • Lower leg arterial calcification (LLAC) is a quantifiable measure of VC in CKD patients.
  • The relationship between LLAC, vascular biomarkers, and bone health in CKD remains unclear.

Purpose of the Study:

  • To investigate the association between LLAC and various biomarkers in CKD patients.
  • To explore the correlation of LLAC with bone turnover and microstructure.
  • To identify independent predictors of LLAC in advanced CKD.

Main Methods:

  • Cross-sectional study involving 69 CKD stages 4-5D patients and 68 healthy controls.
  • Fasting blood samples analyzed for biomarkers.
  • High-resolution peripheral quantitative computed tomography (HRpQCT) assessed bone microstructure.
  • Trans-iliac bone biopsy performed on 43 CKD patients.

Main Results:

  • LLAC was significantly more severe in CKD patients than controls (p < 0.001).
  • CKD patients with diabetes exhibited substantially higher LLAC (p < 0.001).
  • LLAC correlated with serum phosphate, calcium x phosphate product, intact parathyroid hormone (iPTH), intact fibroblast growth factor-23 (iFGF23), and bone turnover markers. LLAC also correlated with poorer distal tibia cortical bone mineral density, thickness, and porosity.
  • No association was found between LLAC and bone turnover, mineralization, or volume on biopsy.

Conclusions:

  • Older age, diabetes, elevated iPTH, and iFGF23 are independently associated with LLAC in advanced CKD.
  • These factors may play crucial roles in the development of LLAC.
  • LLAC serves as a valuable indicator of vascular complications in CKD.
Abstract

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
393
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
384
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
235
Role of Vitamins in Maintaining Bone Health01:25

Role of Vitamins in Maintaining Bone Health

The growth and maintenance of bone are regulated by a combination of nutritional factors, including vitamins, such as vitamin A, B12, C, D, and K.
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
4.6K